Shorter illness duration:
ColdZyme reduced the duration of upper respiratory tract infections.
The evidence behind ColdZyme®
The study shows that ColdZyme shortens illness duration, alleviates symptoms, and reduces viral loads in upper respiratory tract infections. ColdZyme addresses the underlying cause of upper respiratory infections by physically inhibiting the virus's spread and protecting the cells in the airways. The results reinforce ColdZyme’s position as an effective support for fighting the cause of colds, both for athletes and the general public.
Key results from the study
-
-
Reduced viral load:
Rhinovirus levels were significantly reduced in both studies on athletes and cell models.
-
Protected cells:
Infected cells were nearly restored to their normal condition.
The evidence behind ColdZyme®
The study shows that ColdZyme shortens illness duration, alleviates symptoms, and reduces viral loads in upper respiratory tract infections. ColdZyme addresses the underlying cause of upper respiratory infections by physically inhibiting the virus's spread and protecting the cells in the airways. The results reinforce ColdZyme’s position as an effective support for fighting the cause of colds, both for athletes and the general public.
Key results from the study
-
Shorter illness duration:
ColdZyme reduced the duration of upper respiratory tract infections.
-
Reduced viral load:
Rhinovirus levels were significantly reduced in both studies on athletes and cell models.
-
Protected cells:
Infected cells were nearly restored to their normal condition.